S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

BNTC Benitec Biopharma Limited

10.30

-0.76 (-6.87%)

Jan 17 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Benitec Biopharma Charts.

Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Benitec Biopharma Charts.

Benitec Biopharma Limited News

Form 3 - Initial statement of beneficial ownership of securities
Friday 3 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Tuesday 31 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 13 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 10 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 6 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

More Benitec Biopharma Limited News Articles

Royal Caribbean

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions